Biosimilars Market Research Reports 2026 — GCC & MENA Intelligence

GCC biosimilars uptake accelerates via tender mechanics, pharmacist substitution statutes emerging patchwork across emirates, and originator rebate defensive contracting. Oncology trastuzumab biosimilars compete on vial pooling efficiency versus cold chain breakage SLAs.